Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

60.21 +1.22 (+2.07%)

Delayed Quote Updated: 10:21 AM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royalty Pharma plc - Class A Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

January 28, 2025

From Royalty Pharma plc

Via GlobeNewswire

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst ↗

January 22, 2025

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.

Via Benzinga

Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

Top performers in last week's stock market: Walgreens, Constellation Energy, FTAI Aviation, TD SYNNEX, Aurora Innovation, Royalty Pharma, Micron, Delta Air Lines, Intra-Cellular Therapies, United...

Via Benzinga

Insights Ahead: Royalty Pharma's Quarterly Earnings ↗

November 05, 2024

Via Benzinga

Peering Into Royalty Pharma's Recent Short Interest ↗

October 08, 2024

Via Benzinga

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday ↗

January 10, 2025

Via Benzinga

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference

January 10, 2025

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

January 10, 2025

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Announces Dividend Increase

January 09, 2025

From Royalty Pharma plc

Via GlobeNewswire

Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock ↗

December 20, 2024

Jim Cramer likes Walmart (WMT). Walmart provides body cameras to employees in a pilot program. Cramer says Royalty Pharma (RPRX) is a disappointing stock.

Via Benzinga

3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer ↗

December 13, 2024

Via The Motley Fool

2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips ↗

December 04, 2024

Via The Motley Fool

3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer ↗

December 03, 2024

Via The Motley Fool

Royalty Pharma to Present at Upcoming Investor Conferences

November 27, 2024

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

November 14, 2024

From Royalty Pharma plc

Via GlobeNewswire

3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade ↗

November 14, 2024

Via The Motley Fool

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

November 07, 2024

From Royalty Pharma plc

Via GlobeNewswire

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields ↗

November 06, 2024

Via Benzinga

Royalty Pharma Reports Third Quarter 2024 Results

November 06, 2024

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

November 04, 2024

From Royalty Pharma plc

Via GlobeNewswire

3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive Income ↗

October 20, 2024

Buy these stocks now, and the yield on your original investment could reach a double-digit percentage long before you retire.

Via The Motley Fool

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

October 16, 2024

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Declares Fourth Quarter 2024 Dividend

October 11, 2024

From Royalty Pharma plc

Via GlobeNewswire

2 No-Brainer Dividend Stocks to Buy With $100 in October ↗

October 01, 2024

With their high yields and strong underlying businesses, these stocks are hard to pass up.

Via The Motley Fool

2 High-Yield Dividend Stocks Near 52-Week Lows: Are They Buys Now? ↗

September 28, 2024

These dividend-paying stocks offer hard-to-find high yields, but that doesn't necessarily make them good stocks to buy now.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 18, 2024

Via Benzinga

3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade ↗

September 16, 2024

Now could be a great time to scoop up three stocks trading way below their previous peaks.

Via The Motley Fool

2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100 ↗

September 08, 2024

These dividend payers could more than double their payouts in the decade ahead.

Via The Motley Fool

Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut ↗

September 04, 2024

Ascendis Pharma reported lower-than-expected Q2 2024 sales of $38.76 million, missing the consensus estimate of $92.7 million due to a significant adjustment to prior sales estimates. The company...

Via Benzinga

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

September 03, 2024

Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the Yorvipath U.S. commercial launch, and general corporate purposes

From Royalty Pharma plc

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.